- Home
- PPBT vs STSS Comparison
PPBT vs STSS Comparison
Compare PPBT & STSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPBT
- STSS
- Stock Information
- Founded
- PPBT 2010
- STSS 2017
- Country
- PPBT Israel
- STSS United States
- Employees
- PPBT N/A
- STSS N/A
- Industry
- PPBT Biotechnology: Pharmaceutical Preparations
- STSS Medical/Dental Instruments
- Sector
- PPBT Health Care
- STSS Health Care
- Exchange
- PPBT Nasdaq
- STSS Nasdaq
- Market Cap
- PPBT 6.3M
- STSS 5.5M
- IPO Year
- PPBT N/A
- STSS 2022
- Fundamental
- Price
- PPBT $2.40
- STSS $5.70
- Analyst Decision
- PPBT Strong Buy
- STSS
- Analyst Count
- PPBT 1
- STSS 0
- Target Price
- PPBT $33.00
- STSS N/A
- AVG Volume (30 Days)
- PPBT 23.8K
- STSS 2.7M
- Earning Date
- PPBT 08-15-2025
- STSS 08-13-2025
- Dividend Yield
- PPBT N/A
- STSS N/A
- EPS Growth
- PPBT N/A
- STSS N/A
- EPS
- PPBT N/A
- STSS N/A
- Revenue
- PPBT N/A
- STSS N/A
- Revenue This Year
- PPBT N/A
- STSS N/A
- Revenue Next Year
- PPBT N/A
- STSS N/A
- P/E Ratio
- PPBT N/A
- STSS N/A
- Revenue Growth
- PPBT N/A
- STSS N/A
- 52 Week Low
- PPBT $2.00
- STSS $3.36
- 52 Week High
- PPBT $13.95
- STSS $2,224.20
- Technical
- Relative Strength Index (RSI)
- PPBT 47.68
- STSS 45.70
- Support Level
- PPBT $2.26
- STSS $5.29
- Resistance Level
- PPBT $2.45
- STSS $5.78
- Average True Range (ATR)
- PPBT 0.14
- STSS 0.37
- MACD
- PPBT -0.01
- STSS 0.30
- Stochastic Oscillator
- PPBT 44.12
- STSS 71.29
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.
About STSS Sharps Technology Inc.
Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa, Securgard, and Sologard are ultra-low waste smart safety syringes designed to eliminate potentially infectious and accidental needlestick injuries.